Metformin-induced phosphorylation of DOCK1 at Y722 and Y1811 increases the level of RAC1-GTP to activate RAC1 in HCC PLC, SNU-449, and Hep3B cells, contributing to increased cell survival and resistance to metformin. This evidence concerns the gene RAC1 and hepatocellular carcinoma.